
The latest news and exclusive analysis across the FDA-regulated industries from former FDA professionals and industry experts. Save time gathering the critical industry intelligence you need to act on.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 421 | Founded | 4 years ago | Last Issue | 5 days ago |
| Active | |||||

Most small pre-commercial sponsors don’t have the luxury of spending much time thinking about what happens if their drug actually makes it out of Phase 1 and 2 trials.
Most of the time, these teams are small, the budgets are tight, and the...
Specific findings differ from one procedure to another, but a few overarching gaps tend to be the same.
We’ve run SOP gap analyses across a wide range of organizations: device manufacturers, pharma sponsors, CROs, and clinical sites.
FDA Commissioner Marty Makary announced a new inspection pilot yesterday morning at the Food and Drug Law Institute Annual Conference in Washington. The FDA also made an official announcement on its website.
The agency has been conducting...
A quick breakdown of CBER's final guidance on CMC flexibilities for human CGT product development.
This guidance breakdown is available in full to paid subscribers. Only paid subscribers get regular full access to our guidance breakdowns a...
Many sponsors we talk to still think about resourcing their ClinOps functions in one of two ways: Either open a full-time req and wait, or outsource the work. But we've seen more teams moving away from that binary, and the companies getting...
Subscribers, engagement, traffic and sponsorship for The FDA Group's Insider Newsletter.
| Subscribers | Engagement | 78 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #86 |
The writers behind this newsletter.
The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates.
You can find recent issues that have been published by The FDA Group's Insider Newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The FDA Group's Insider Newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The FDA Group's Insider Newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The FDA Group's Insider Newsletter using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like The FDA Group's Insider Newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.